Chronic fatigue syndrome (CFS) is characterized by severe fatigue, lasting for at least 6 months, for which no somatic explanation can he found. Because hyperventilation can produce substantial fa tigue, it seems worthwhile to investigate the relationship between it and CFS. It might be hypothesized that hyperventilation plays a causal or perpetuating role in CFS. CFS patients, non-CFS patients known to experience hyperventilation, and healthy controls were compared on complaints of fatigue and hyper ventilation. CFS patients and non-CFS patients known to experience hyperventilation offered substan tial complaints of fatigue and hyperventilation, both to a similar degree. Physiological evidence of hyper ventilation was found significantly more often in CFS patients than in healthy controls. However, no significant differences between CFS patients with and CFS patients without hyperventilation were found on severity of fatigue, impairment, number of complaints, activity level, psychopathology, and depres sion. It is concluded that hyperventilation in CFS should probably be regarded as an epiphenomenon. © 1997 Elsevier Science Inc.
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CFS might develop hyperventilation due to their fatigue, and hyperventilation might in turn lead to an aggravation of fatigue.
Only a few studies have dealt with the relationship between CFS and hyperventi lation. Rosen et al. [7] demonstrated hyperventilation in 38 of 40 patients suffering from CFS and claimed that hyperventilation plays an important role in the patho genesis. Riley et al. [4] , however, found no differences in the mean end-tidal Pco2 both before and after exercise between 13 patients with CFS and 13 healthy con trols. Saisch et al. [8] found evidence for hyperventilation in 9% of 31 CFS patients (29%). They did not find a relationship between the severity of hyperventilation and the degree of functional impairment, which was to be expected when hyperven tilation would play a perpetuating role in CFS.
The first purpose of the present study is to determine whether there is any evi dence for subjective complaints of hyperventilation in CFS, and whether there is ev idence of fatigue in patients with hyperventilation. CFS patients and patients with known hyperventilation are compared to healthy controls to see whether these complaints are not only common but also specific for CFS and hyperventilation. The aim of the second part of the study is to determine whether there is any physio logical evidence for hyperventilation in CFS and whether CFS patients show physi ological evidence for hyperventilation more frequently than healthy controls. In the third part of the study, CFS patients with physiological evidence for hyperventila tion (CFS HV) are compared to CFS patients without hyperventilation (CFS non-HV) on severity of fatigue, impairment, number of complaints, activity level, psy chopathology. and depression, to determine the role of hyperventilation in CFS.
M E T H O D

Subjects
For the first part of this study, 39 patients with CFS and 32 healthy controls (all from a sample de scribed elsewhere) (9) , completed the questionnaires. The healthy controls were matched and recruited by a regional newspaper advertisement. Furthermore, 17 non-CFS patients with established hyperventi lation (non-CFS HV) participated, all from the out-patient clinic of the Department of Pulmonology, Dekkerswald, University of Nijmegen. For the second and third parts of the study 27 CFS patients and the 32 healthy controls from the first part of 'he study participated. The experimental groups are not of an equal size because this study was linked to an already ongoing study.
All CFS patients were diagnosed at the General Internal Medicine out-patient clinic of the University Hospital. Nijmegen. CFS is defined as severe fatigue, lasting for at least 6 months, for which no somatic explanation can be offered. Patients were diagnosed with CFS if they fulfilled the Sharpe criteria [10] . According to these criteria, patients with a current diagnosis of major depression with melancholic or psychotic features, bipolar affective disorder, schizophrenia of any subtype, delusional disorders of any subtype, manic depressive illness, substance abuse, eating disorder, or proven organic brain disease (de mentias of any subtype) were excluded. Patients and healthy controls were diagnosed as having hyperventilation when they fulfilled three of the following criteria [1 1 ]:
• Low Paco2 in rest (<4.5 kPa).
• High breathing frequency, irregular breathing, or frequent sighing in rest.
• Decreasing Paco2 in control condition on a spirometer. • Inverted ventilatory response to co2.
• Adding co2 results in a regulation of breathing.
• One of the following criteria during or after the provocation test: no step change in Petco2 when stopping voluntary hyperventilation; no step change in respiratory frequency when stopping voluntary hyperventilation; Paco2 3 minutes after the end of the provocation <90% of the starting level.
In stru m en ts
Subjective fatigue was measured with the subscale of subjective fatigue of the Checklist of Individual Strength (CIS) [12] . On this scale, the minimum score is 1 and the maximum score is 7.
Level o f impairment was assessed with the Sickness Impact Profile (SIP) [13] . This questionnaire mea sures the influence of complaints in different areas of daily functioning. For this study, eight subscales were used (alertness behavior, sleep, homemaking, leisure activities, work, mobility, social interac tions, ambulation).
Level o f physical activity was assessed using an actometer. This apparatus is worn around the ankle for 2 weeks, recording the amount of movements every 5 minutes. This information is stored to an inter nal memory, and can be read by use of a personal computer [14] .
Subjective complaints o f hyperventilation were assessed by the Nijmegen Hyperventilation Question naire (NHQ) [15] . The cutoff score for hyperventilation is 23.
Psychopathology was measured with the Symptom Checklist (SCL-90R), an indicator of psychological disturbances, and the Beck Depression Inventory (BDI) [16, 17] , a standardized self-report question naire for measuring depression.
Respiratory measurements were performed using a hyperventilation test in which the patient was con nected to a closed spirometer circuit by a mouthpiece. A sampling capnograph measured Pco2 in the re spiratory air. Resting respiratory parameters were measured during 5 minutes: minute ventilation, Petro:, breathing frequency, irregularity of breathing, and the time course of Petco2 during the first 5 minutes of the test. Next, some co; was given in the inspiratory air, to raise Pctco2 by 1.0±0.2 kPa. The response of the ventilation to the increase in Petco2 was measured during another 5 minutes. Subse quently, the patient was disconnected from the spirometer, and only Petco2 was monitored during a 1-minute period of voluntary hyperventilation, and during the 3 minutes thereafter. The patients were asked whether they recognized their daily symptoms, during the hyperventilation. Finally, an arterialized capillary blood gas sample was taken to assess a possible metabolic acidosis, compensating for chronic hyperventilation.
S tutistica l a nu Iy ses
The analysis of differences between groups on dichotomous variables was carried out with the chisquare test. Bonferroni correction was applied for the comparison of three experimental groups. Assum ing a significance level of 0.05, a difference was considered significant if the p<0.017. The analysis of dif ferences between two groups on ratio variables was carried out with the /-test, with the significance level set at p -0.05. The analysis of differences between more than two groups on ratio variables was per formed bv analysis of variance. Multiple comparisons were made bv Duncan's multiple range tests, with /;<0.05.
RESU LTS
First part
The mean age of the CFS patients was 36.5 (s d =8.8), of the non-CFS patients with known hyperventilation (non-CFS HV) 44.0 (s d = 12.6), and of the healthy controls 37.0 (s d = 12.8). Only the non-CFS HV patients differed significantly in age from the other two groups. There were no significant differences in gender: 80% of the CFS patients were female, as were 59% of the non-CFS HV patients and 84% of the healthy controls.
Data concerning subjective complaints of hyperventilation and subjective com plaints of fatigue are presented in Table I . On the NHQ, 59% of the CFS patients scored above the cutoff score for hyperventilation. This is significantly different from healthy controls (3%), but not from non-CFS HV patients (65%). Non-CFS HV patients had a mean CIS score for subjective fatigue of 5.2. This is significantly different from healthy controls (2.0), but not from CFS patients (5.9).
Second part
The CFS patients and the healthy controls who underwent respiratory measure ments did not differ significantly on age and gender. Mean age of the CFS patients 2.0 ( 1.1 ) a One-way A N O V A with Duncan multiple-range test ( p < 0.05), CFS sig nificantly different from non-CFS HV, and healthy controls, and non-CFS HV significantly different from healthy controls.
hp < 0.001; CFS significantly different from healthy controls (p < 0.001), and non-CFS HV significantly different from healthy controls (p < 0.001); non-CFS HV is not significantly different from CFS. tween CFS patients and healthy controls significant differences were found on fa tigue, impairment, number of complaints, level of activity, subjective complaints of hyperventilation, and psychopathology, as expected [9] (Table II) . Table III shows the results of the respiratory measurements in CFS and healthy controls. Significantly more CFS patients showed hyperventilation (59%) than did healthy controls (22%). CFS patients differed from healthy controls on Petco: and recognition of complaints, but not on the other respiratory parameters.
Third part
The 16 CFS patients with hyperventilation (CFS HV) and the 11 CFS patients without hyperventilation (CFS non-HV) were compared on subjective fatigue (CIS), impairment (SIP), number of complaints, activity level (actometer), subjec tive complaints specific for hyperventilation (NHQ score), psychopathology (SCL-90) and depression (BDI). No significant differences between groups were found (Table IV) . CFS HV patients as well as CFS non-HV patients were both extremely fatigued and impaired. There was neither a significant difference in the number of complaints, nor the level of activity or subjective complaints of hyperventilation. Fi nally, CFS-FIV patients and CFS non-HV patients did not differ on psychopathol ogy and depression.
DISCUSSION
Patients with CFS endorsed subjective complaints of hyperventilation, similar to non-CFS patients with known hyperventilation. The latter showed substantial fa tigue, of similar severity as CFS patients. Physiological evidence for hyperventila tion was found significantly more often in CFS patients (59%) than in healthy con trols (22%), with a significant difference in the mean resting Petco2. Rosen et al. [7] found hyperventilation in 93% of the CFS patients and 55% of the healthy controls. whereas Saisch et al. [8] found evidence for hyperventilation in 29% of the CFS pa tients, and Riley et al. [4] found no differences in the mean Petco2 between CFS pa tients and healthy controls. These conflicting findings can be explained by the differ ences in the criteria used in diagnosing hyperventilation. In the study by Rosen et al. [7] , less stringent criteria were used. Patients were also diagnosed with hyperven tilation if they had a positive "think test": 3 minutes after the hyperventilation prov ocation test, patients were requested to close their eyes and think about the circum stances of an attack and the feelings and sensations experienced. A fall of end-tidal Paco2 of 1.3 kPa or more was taken as a positive response [18] . However, the resting Petco2 in that study did not differ between CFS patients and healthy controls, as in the study of Riley et al. [4] . In the study by Saisch et al. [8] , the criteria were more strict than in our study. Patients were diagnosed with hyperventilation only if the Petco2 was less than 4.0 kPa at rest, during or after exercise, or at 5 minutes after the end of voluntary overbreathing. Using the criterion of a Petco2 of less than 4.0 kPa, in our study, 19% of the CFS patients and none of the healthy controls were diagnosed with hyperventilation. This is closer to the finding of 29% hyperventilat ing CFS patients found in the study by Saisch et al. [8] .
If hyperventilation plays an important role in the pathogenesis or perpetuation of CFS, one would assume that hyperventilation is common in CFS, and one would ex pect higher scores of fatigue and impairment in the CFS patients with hyperventila tion, compared to the CFS patients without hyperventilation. Like Saisch et al. [8] , we found physiological evidence for hyperventilation in some of the CFS patients, the exact percentage depending on the criteria used. In addition, we could show that the high percentage of 93% found in the study by Rosen et al. [7] could be explained by the less strict criteria used: hyperventilation in CFS is not as common as they sug gest. Comparing CFS patients with hyperventilation to CFS patients without hyper ventilation, no differences on fatigue and impairment were found, as in the study by Saisch et al. [8] . There were also no differences found on variables such as the number of complaints, level of activity, psychopathology, and depression. If hyper ventilation plays a role in CFS, one would at least expect some differences. Using the strict criteria of a 4.0 kPa Paco2 at rest, five of our CFS patients showed hyper ventilation. However, even then, no differences are found between CFS patients with and CFS patients without hyperventilation. Therefore, it is unlikely that hyper ventilation plays a role in the pathogenesis or perpetuation of CFS.
Depending on the criteria one uses, it can be said that signs of hyperventilation were found in a substantial number of the CFS patients. Furthermore, non-CFS HV pa tients had significantly more complaints of fatigue than healthy controls. However, we did not find more complaints of fatigue in hyperventilating CFS patients than in nonhvperventilating CFS patients. Therefore, hyperventilation is probably an epiphenomenon in CFS, and does not play a substantial causal or perpetuating role.
